Heinze K, Nazeran TM, Lee S, Kramer P, et al. Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8(+) TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas. J Pathol 2022;256:388-401.
PMID: 34897700